Catheter Ablation of Ventricular Fibrillation in Structurally Normal Hearts Targeting the RVOT and Purkinje Ectopy

Herz

Volumn 28, Issue 7, 2003, Pages 598-606

  Weerasooriya, Rukshen ^b   Hsu, Li Fern ^b   Scavée, Christophe ^b   Sanders, Prashanthan ^b   Hocini, Mélèze ^b   Cabrera, Jose A ^b   Horlitz, Marc ^b   Schley, Philipp ^b   Guelker, Hartmut ^b   Jaïs, Pierre ^b   Haïssaguerre, Michel ^a  

^a HAUT LÉVÊQUE HOSPITAL   (France)

^b NONE

Author keywords

Catheter ablation; Sudden death; Ventricular fibrillation

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; FLECAINIDE; PROPAFENONE; QUINIDINE; VERAPAMIL;

ARTICLE; BRUGADA SYNDROME; CATHETER ABLATION; DEFIBRILLATOR; DISEASE ASSOCIATION; DISEASE EXACERBATION; DRUG EFFICACY; ECG ABNORMALITY; ELECTROCARDIOGRAM; ELECTROPHYSIOLOGY; FAMILY HISTORY; FLUOROSCOPY; FOLLOW UP; HEART ARRHYTHMIA; HEART LEFT VENTRICLE; HEART REPOLARIZATION; HEART RIGHT VENTRICLE OUTFLOW TRACT; HEART VENTRICLE EXTRASYSTOLE; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HOLTER MONITORING; HUMAN; LEFT VENTRICULAR ABNORMAL REPOLARIZATION SYNDROME; LONG QT SYNDROME; MICROELECTRODE; PURKINJE CELL; QRS COMPLEX; QT INTERVAL; RADIOFREQUENCY; RECURRENT DISEASE; SUDDEN DEATH; SYNDROME; TARGET ORGAN; TORSADE DES POINTES; TREATMENT FAILURE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; BODY SURFACE POTENTIAL MAPPING; CATHETER ABLATION; DEATH, SUDDEN, CARDIAC; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; ELECTROPHYSIOLOGIC TECHNIQUES, CARDIAC; FEMALE; FOLLOW-UP STUDIES; HEART VENTRICLES; HUMANS; LONG QT SYNDROME; MALE; MIDDLE AGED; MULTICENTER STUDIES; PURKINJE FIBERS; STROKE VOLUME; SYNDROME; TIME FACTORS; VENTRICULAR FIBRILLATION; VENTRICULAR OUTFLOW OBSTRUCTION; VENTRICULAR PREMATURE COMPLEXES;

EID: 10744221250     PISSN: 03409937     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00059-003-2491-y     Document Type: Article

References (24)

1. Zipes DP, Wellens HJJ. Sudden cardiac death. Circulation 1998;21:2334-51.
2. Zipes DP. Implantable cardioverter-defibrillator: A Volkswagen or a Rolls Royce: how much will we pay to save a life? Circulation 2001;103:1372-4.
3. Moss AJ, Hall WJ, Cannom DS, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med 1996;335:1933-40.
4. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 1997;337:1576-83.
5. Kuck KH, Cappato R, Siebels J, et al. Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: the Cardiac Arrest Study Hamburg (CASH). Circulation 2000;102:748-54.
6. Belhassen B, Viskin S. Idiopathic ventricular tachycardia and fibrillation. J Cardiovasc Electrophysiol 1993;4356-68.
7. Leenhardt A, Glaser E, Burguera M, et al. Short-coupled variant of torsades de pointes. A new electrocardiographic entity in the spectrum of idiopathic ventricular tachyarrhythmias. Circulation 1994;89:206-15.
8. Eisenberg SJ, Scheinman MM, Dullet NK, et al. Sudden cardiac death and polymorphous ventricular tachycardia in patients with normal QT intervals and normal systolic cardiac function. Am J Cardiol 1995;75:687-92.
9. Ledwitch JR, Fay JE. Idiopathic recurrent ventricular fibrillation. Am J Cardiol 1969;190:781-3.
10. Consensus Statement of the Joint Committees of the Unexplained Cardiac Arrest Registry of Europe and of the Idiopathic Ventricular Fibrillation Registry in the United States. Survivors of out-of-hospital cardiac arrest with apparently normal heart. Need for definition and standardized clinical evaluation. Circulation 1996;95:265-72.
11. Haïssaguerre M, Shah DC, Jaïs P, et al. Role of Purkinje conducting system in triggering of idiopathic ventricular fibrillation. Lancet 2002;359:677-8.
12. Haïssaguerre M, Shoda M, Jaïs P, et al. Mapping and ablation of ventricular fibrillation. Circulation 2002;106:962-7.
13. Saliba W, Abul Karim A, Tchou P, et al. Ventricular fibrillation: ablation of a trigger? J Cardiovasc Electrophysiol 2002;13:1296-9.
14. Aizawa Y, Tamura M, Chinushi M, et al. An attempt at electrical catheter ablation of the arrhythmogenic area in idiopathic ventricular fibrillation. Am Heart J 1992;95:572-6.
15. Ashida K, Kaji Y, Sasaki Y. Ablation of torsades de pointes after radiofrequency catheter ablation at right ventricular outflow tract. Int J Cardiol 1997;59:171-5.
16. Kusano KF, Yamamoto M, Emori T, et al. Successful catheter ablation in a patient with polymorphic ventricular tachycardia. J Cardiovasc Electrophysiol 2000;11:682-5.
17. Takatsuki S, Mitamura H, Ogawa S. Catheter ablation of a monofocal premature ventricular complex triggering idiopathic ventricular fibrillation. Heart 2001;86:e3.
18. Haïssaguerre M, Weerasooriya R, Walczack F, et al. Catheter ablation of polymorphic VT or VF in multiple substrates. In: Santini M, ed. Non pharmacologic treatment of sudden death. Bologna: Arianna, 2003.
19. Lerman BB, Stein K, Markowitz SM, et al. Ventricular tachycardia in patients with structurally normal hearts. In: Zipes DP, Jalife J, eds. Cardiac electrophysiology: from cell to bedside. Philadelphia: Saunders, 2000:640-54.
20. Movsowitz C, Schwartzman D, Callans DJ, et al. Idiopathic right ventricular outflow tract tachycardia: narrowing the anatomic location for successful ablation. Am Heart J 1996;131:930-6.
21. Haïssaguerre M, Extramania F, Hocini M, et al. Mapping and ablation of ventricular fibrillation associated with long-QT and Brugada syndromes. Circulation 2003;108:925-8.
22. Morita H, Fukushima-Kusano K, et al. Site-specific arrhythmogenesis in patients with Brugada syndrome. J Cardiovasc Electrophysiol 2003;14:373-9.
23. Kakishita M, Kurita T, Matsuo K, et al. Mode of onset of ventricular fibrillation in patients with Brugada syndrome detected by implantable cardioverter defibrillator therapy. J Am Coll Cardiol 2000;36:1646-53.
24. Ouyang F, Fotuhi P, Ho SY, et al. Repetitive monomorphic ventricular tachycardia originating from the aortic sinus cusp: electrocardiographic characterization for guiding catheter ablation. J Am Coll Cardiol 2002;39:500-8.